David W Ollila

UNCCH, School of Medicine, Surgery

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

David W Ollila

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Surgery
  
  

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Carrie Lee; Frances Collichio; David Ollila; Stergios Moschos

  Historical review of melanoma treatment and outcomes

  Clinics in Dermatology. 2013;31(2):141-147.
  0

• 2.

  2013

  Sarah L. Blair; Derek K. Emerson; Swati Kulkarni; E. Shelley Hwang; Vanessa Malcarne; David W. Ollila

  Breast surgeon's survey: No consensus for surgical treatment of pleomorphic lobular carcinoma in situ

  Breast Journal. 2013;19(1):116-118.
  0

• 3.

  2013

  Noam A. Vanderwalde; Ellen L. Jones; Randall J. Kimple; Dominic T. Moore; Nancy Klauber-Demore; Carolyn I. Sartor; David W. Ollila

  Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: Six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria

  Cancer. 2013;119(9):1736-1743.
  0

• 4.

  2012

  Clara N. Lee; Yuchiao Chang; Nesochi Adimorah; Jeff K. Belkora; Beverly Moy; Ann H. Partridge; David W. Ollila; Karen R. Sepucha

  Decision making about surgery for early-stage breast cancer

  Journal of the American College of Surgeons. 2012;214(1):1-10.
  3

• 5.

  2012

  Wenjin Liu; Kimberly B. Monahan; Adam D. Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T. Chan; David W. Roadcap; David W. Ollila; Nancy E. Thomas; Diego H. Castrillon; et al.

  LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma

  Cancer Cell. 2012;21(6):751-764.
  6

• 6.

  2012

  Justin J. Baker; David W. Ollila; Allison M. Deal; Jill Frank; Keith D. Amos; Michael O. Meyers

  Early recurrence in sentinel lymph node positive stage III melanoma patients

  American Surgeon. 2012;78(7):808-813.
  1

• 7.

  2012

  Cathleen M. Sybert Khandelwal; Michael O. Meyers; Jen Jen Yeh; Keith D. Amos; Jill S. Frank; Patricia Long; David W. Ollila

  Relative value unit impact of complex skin closures to academic surgical melanoma practices

  American Journal of Surgery. 2012;204(3):327-331.
  0

• 8.

  2012

  Randall J. Kimple; Janet K. Horton; Chad A. Livasy; Janiel M. Shields; Julia A. Lawrence; Wingkeung M. Chiu; Anastasia Ivanova; David W. Ollila; Lisa A. Carey; Jan S. Halle; et al.

  Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer

  Oncologist. 2012;17(12):1496-1503.
  0

• 9.

  2011

  Randall J. Kimple; Nancy Klauber-Demore; Cherie M. Kuzmiak; Dag Pavic; Jun Lian; Chad A. Livasy; Laura Esler; Dominic T. Moore; Carolyn I. Sartor; et al.

  Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy

  International Journal of Radiation Oncology Biology Physics. 2011;79(2):400-407.
  4

• 10.

  2011

  Frederick Moffat; Kelly McMasters; Hiram Polk; Richard Reiling; David Ollila; Marshall M. Urist; William C. Wood; Steven Hochwald

  Discussion

  Journal of the American College of Surgeons. 2011;212(4):460-462.
  0

• 11.

  2011

  Randall J. Kimple; Nancy Klauber-DeMore; Cherie M. Kuzmiak; Dag Pavic; Jun Lian; Chad A. Livasy; Wing Keung M. Chiu; Dominic T. Moore; Carolyn I. Sartor; David W. Ollila

  Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer

  Annals of Surgical Oncology. 2011;18(4):939-945.
  4

• 12.

  2011

  David W. Ollila; Ana L. Gleisner; Eddy C. Hsueh

  Rationale for complete metastasectomy in patients with stage IV metastatic melanoma

  Journal of Surgical Oncology. 2011;104(4):420-424.
  3

• 13.

  2011

  Michael O. Meyers; Nancy Klauber-Demore; David W. Ollila; Keith D. Amos; Dominic T. Moore; Amy A. Drobish; Emily M. Burrows; E. Claire Dees; Lisa A. Carey

  Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer

  Annals of Surgical Oncology. 2011;18(10):2851-2857.
  8

• 14.

  2011

  David W. Ollila

  A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430

  Cancer. 2011;117(20):4579-4581.
  0

• 15.

  2011

  John F. Thompson; David W. Ollila

  Optimum excision margins for melanoma

  The Lancet. 2011;378(9803):1608-1610.
  1

• 16.

  2010

  Michael O. Meyers; Jen Jen Yeh; Allison M. Deal; Faera L. Byerly; John T. Woosley; Jill Frank; Patricia K. Long; Keith D. Amos; David W. Ollila

  Age and breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melanocytic tumors of uncertain malignant potential

  Journal of the American College of Surgeons. 2010;211(6):744-748.
  2

• 17.

  2010

  Janet K. Horton; Jan Halle; Madlyn Ferraro; Lisa Carey; Dominic T. Moore; David Ollila; Carolyn I. Sartor

  Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer With Trastuzumab: A Phase II Trial

  International Journal of Radiation Oncology Biology Physics. 2010;76(4):998-1004.
  14

• 18.

  2010

  Nancy E. Thomas; Peter A. Kanetsky; Sharon N. Edmiston; Audrey Alexander; Colin B. Begg; Pamela A. Groben; Honglin Hao; Klaus Busam; David W. Ollila; Marianne Berwick; et al.

  Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study

  Journal of Investigative Dermatology. 2010;130(5):1463-1465.
  6

• 19.

  2009

  Michael O. Meyers; Jen Jen Yeh; Jill Frank; Patricia Long; Allison M. Deal; Keith D. Amos; David W. Ollila

  Method of detection of initial recurrence of stage II/III cutaneous melanoma: Analysis of the utility of follow-up staging

  Annals of Surgical Oncology. 2009;16(4):941-947.
  12

• 20.

  2009

  David W. Ollila; Jean H. Ashburn; Keith D. Amos; Jen Jen Yeh; Jill S. Frank; Allison M. Deal; Patricia Long; Nancy D. Thomas; Michael O. Meyers

  Metastatic Melanoma Cells in the Sentinel Node Cannot Be Ignored

  Journal of the American College of Surgeons. 2009;208(5):924-929.
  18

• 21.

  2009

  Michael O. Meyers; Christina P. Russell; David W. Ollila; Jen Jen Yeh; Hong Jin Kim; Benjamin F. Calvo

  Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet

  American Surgeon. 2009;75(9):843-847.
  1

• 22.

  2009

  Sarah L. Blair; Kari Thompson; Joseph Rococco; Vanessa Malcarne; Peter D. Beitsch; David W. Ollila

  Attaining Negative Margins in Breast-Conservation Operations: Is There a Consensus among Breast Surgeons?

  Journal of the American College of Surgeons. 2009;209(5):608-613.
  31

• 23.

  2007

  Matthew M. Mondi; Rosa E. Cuenca; David W. Ollila; John H. Stewart Iv; Edward A. Levine

  Sentinel lymph node biopsy during pregnancy: Initial clinical experience

  Annals of Surgical Oncology. 2007;14(1):218-221.
  43

• 24.

  2007

  Karyn B. Stitzenberg; Nancy E. Thomas; Kathleen Dalton; Sarah E. Brier; David W. Ollila; Marianne Berwick; Dianne Mattingly; Robert C. Millikan

  Distance to diagnosing provider as a measure of access for patients with melanoma

  Archives of Dermatology. 2007;143(8):991-998.
  18

• 25.

  2007

  Anne M. Lachiewicz; Todd M. Wilkinson; Pamela Groben; David W. Ollila; Nancy E. Thomas

  Muir-Torre syndrome

  American Journal of Clinical Dermatology. 2007;8(5):315-319.
  9

• 26.

  2007

  Karyn B. Stitzenberg; Nancy E. Thomas; David W. Ollila

  Influence of provider and practice characteristics on melanoma care

  American Journal of Surgery. 2007;193(2):206-212.
  1

• 27.

  2007

  David W. Ollila; Nancy Klauber-DeMore; Leora J. Tesche; Cherie M. Kuzmiak; Dag Pavic; Lav K. Goyal; Jun Lian; Sha Chang; Chad A. Livasy; et al.

  Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively

  Annals of Surgical Oncology. 2007;14(2):660-669.
  15

• 28.

  2007

  Lisa A. Carey; E. Claire Dees; Lynda Sawyer; Lisa Gatti; Dominic T. Moore; Frances Collichio; David W. Ollila; Carolyn I. Sartor; Mark L. Graham; Charles M. Perou

  The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes

  Clinical Cancer Research. 2007;13(8):2329-2334.
  583

• 29.

  2007

  Karyn B. Stitzenberg; Nancy Klauber-Demore; Xiao Sha Chang; Benjamin F. Calvo; David W. Ollila; Lav K. Goyal; Michael O. Meyers; Hong Jin Kim; Joel E. Tepper; Carolyn I. Sartor

  In vivo intraoperative radiotherapy: A novel approach to radiotherapy for early stage breast cancer

  Annals of Surgical Oncology. 2007;14(4):1515-1516.
  6

• 30.

  2007

  Nancy E. Thomas; Sharon N. Edmiston; Audrey Alexander; Robert C. Millikan; Pamela A. Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B. Begg; et al.

  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma

  Cancer Epidemiology Biomarkers and Prevention. 2007;16(5):991-997.
  57

• 31.

  2006

  John Phay; David W. Ollila; Abigail S. Caudle

  Discussion

  American Surgeon. 2006;72(9):790.
  0

• 32.

  2006

  Abigail S. Caudle; Sarah E. Brier; Benjamin F. Calvo; Jin Kim Hong; Michael O. Meyers; David W. Ollila

  Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays

  American Surgeon. 2006;72(9):785-789.
  12

• 33.

  2006

  David W Ollila

  Complete metastasectomy in patients with stage IV metastatic melanoma

  Lancet Oncology. 2006;7(11):919-924.
  54

• 34.

  2006

  Patricia K. Long; David W. Ollila

  Cutaneous melanoma, part two: Management of patients with biopsy-proven melanoma

  Geriatrics and Aging. 2006;9(7):491-493.
  0

• 35.

  2006

  Patricia K. Long; David W. Ollila

  Detection and diagnosis of cutaneous melanoma

  Geriatrics and Aging. 2006;9(5):346-349.
  0

• 36.

  2006

  David W. Ollila; Abigail S. Caudle; William G. Cance; Hong Jin Kim; James C. Cusack; Judith E. Swasey; Benjamin F. Calvo

  Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays

  American Journal of Surgery. 2006;191(1):52-56.
  22

• 37.

  2006

  Karyn B. Stitzenberg; Nancy E. Thomas; Laura M. Beskow; David W. Ollila

  Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma

  Journal of Surgical Oncology. 2006;93(2):100-107.
  10

• 38.

  2006

  Nancy Klauber-DeMore; David W. Ollila; Dominic T. Moore; Chad Livasy; Benjamin F. Calvo; Jin Kim Hong; E. Claire Dees; Carolyn I. Sartor; Lynda R. Sawyer; Mark Graham II; et al.

  Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic

  Annals of Surgical Oncology. 2006;13(5):685-691.
  16

• 39.

  2006

  David W. Ollila; Abigail S. Caudle

  Surgical Management of Distant Metastases

  Surgical Oncology Clinics of North America. 2006;15(2):385-398.
  14

• 40.

  2006

  Heather Neuman; Lisa A. Carey; David W. Ollila; Chad Livasy; Benjamin F. Calvo; Anthony A. Meyer; Hong Jin Kim; Michael O. Meyers; E. Claire Dees; Fran A. Collichio; et al.

  Axillary lymph node count is lower after neoadjuvant chemotherapy

  American Journal of Surgery. 2006;191(6):827-829.
  25

• 41.

  2005

  Jonathan C. Samuel; David W. Ollila

  Prophylaxis and screening options: Recommendations for young women with BRCA mutations

  Breast Disease. 2005;23:31-35.
  6

• 42.

  2005

  Erika L. Rager; Edward P. Bridgeford; David W. Ollila

  Cutaneous melanoma: Update on prevention, screening, diagnosis, and treatment

  American Family Physician. 2005;72(2):269-276.
  35

• 43.

  2005

  Lisa A. Carey; Richard Metzger; E. Claire Dees; Frances Collichio; Carolyn I. Sartor; David W. Ollila; Nancy Klauber-DeMore; Jan Halle; Lynda Sawyer; Dominic T. Moore; et al.

  American joint committee on cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome

  Journal of the National Cancer Institute. 2005;97(15):1137-1142.
  80

• 44.

  2005

  David W. Ollila; Heather B. Neuman; Carolyn Sartor; Lisa A. Carey; Nancy Klauber-Demore

  Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers

  American Journal of Surgery. 2005;190(3):371-375.
  20

• 45.

  2005

  Nancy Klauber-DeMore; Benjamin F. Calvo; C. Scott Hultman; Jin Kim Hong; Michael O. Meyers; Lynn Damitz; Jill S. Frank; Karen B. Stitzenberg; Carolyn I. Sartor; David W. Ollila

  Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients

  American Journal of Surgery. 2005;190(4):595-597.
  11

• 46.

  2004

  Reiko F. Irie; David W. Ollila; Steven O'Day; Donald L. Morton

  Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

  Cancer Immunology, Immunotherapy. 2004;53(2):110-117.
  24

• 47.

  2004

  Nancy E. Thomas; Audrey Alexander; Sharon N. Edmiston; Eloise Parrish; Robert C. Millikan; Marianne Berwick; Pamela Groben; David W. Ollila; Dianne Mattingly; Kathleen Conway

  Tandem BRAF mutations in primary invasive melanomas

  Journal of Investigative Dermatology. 2004;122(5):1245-1250.
  34

• 48.

  2004

  Nancy Klauber-Demore; Cherie Kuzmiak; Erika L. Rager; Oyinkansola B. Ogunrinde; David W. Ollila; Benjamin F. Calvo; Hong Jin Kim; Anthony Meyer; Claire Dees; Mark Graham II; et al.

  High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer

  American Journal of Surgery. 2004;188(4 SPEC. ISS.):386-389.
  8

• 49.

  2004

  Karyn B. Stitzenberg; Pamela A. Groben; Stacey L. Stern; Nancy E. Thomas; Thomas A. Hensing; Leah B. Sansbury; David W. Ollila

  Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness ≤1.0 mm)

  Annals of Surgical Oncology. 2004;11(10):900-906.
  43

• 50.

  2003

  Karyn B. Stitzenberg; Anthony A. Meyer; Stacey L. Stern; William G. Cance; Benjamin F. Calvo; Nancy Klauber-DeMore; Hong Jin Kim; Leah Sansbury; David W. Ollila; William C. Wood; et al.

  Extracapsular Extension of the Sentinel Lymph Node Metastasis: A Predictor of Nonsentinel Node Tumor Burden

  Annals of Surgery. 2003;237(5):607-613.
  50

• 51.

  2003

  Michael E. Poole; Stephen A. Bernard; Mary Ann Churchel; Mark C. Weissler; Benjamin Calvo; William Cance; David Ollila; Mark Koruda; Kevin Behrns; et al.

  A phase I study of gemcitabine and docetaxel for advanced stage solid tumors

  Cancer Investigation. 2003;21(3):350-354.
  5

• 52.

  2002

  Karyn B. Stitzenberg; Benjamin F. Calvo; Mary V. Iacocca; Brian H. Neelon; Leah B. Sansbury; Lynn G. Dressler; David W. Ollila

  Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer

  American Journal of Clinical Pathology. 2002;117(5):729-737.
  37

• 53.

  2002

  Paola A. Gehrig; J.F. Boggess; D.W. Ollila; P.A. Groben; L. Van Le

  Appendix cancer mimicking ovarian cancer

  International Journal of Gynecological Cancer. 2002;12(6):768-772.
  7

• 54.

  2002

  Eddy C. Hsueh; Richard Essner; Leland J. Foshag; David W. Ollila; Guy Gammon; Steven J. O'Day; Peter D. Boasberg; Stacey L. Stern; Xing Ye; Donald L. Morton

  Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine

  Journal of Clinical Oncology. 2002;20(23):4549-4554.
  128

• 55.

  2002

  William G. Cance; Lisa A. Carey; Benjamin F. Calvo; Carolyn Sartor; Lynda Sawyer; Dominic T. Moore; Julian Rosenman; David W. Ollila; Mark Graham II

  Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: Effective clinical downstaging allows breast preservation and predicts outstanding local control and survival

  Annals of Surgery. 2002;236(3):295-303.
  68

• 56.

  2001

  David W. Ollila; Karyn B. Stitzenberg

  Breast cancer sentinel node metastases: Histopathologic detection and clinical significance

  Cancer Control. 2001;8(5):407-414.
  14

• 57.

  2001

  D.W. Ollila; L.A. Carey; C.I. Sartor

  Clinical significance micrometastatic disease in the era of sentinel node

  Breast Disease. 2001;12:57-67.
  1

• 58.

  2001

  D.W. Ollila; E.L. Rager

  Lymphatic mapping and sentinel lymphadenectomy: Critical review of technique

  Breast Disease. 2001;13:77-84.
  0

• 59.

  2001

  T.S. Sadiq; W.W. Burns III; D.J. Taber; L. Damitz; D.W. Ollila

  Blue urticaria: A previously unreported adverse event associated with isosulfan blue

  Archives of Surgery. 2001;136(12):1433-1435.
  23

• 60.

  1999

  D.W. Ollila; M.B. Brennan; A.E. Giuliano

  The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer.

  Advances in surgery. 1999;32:349-364.
  27

• 61.

  1999

  A.E. Giuliano; D.W. Ollila; N.M. Hansen; S.E. Singletary; D. Reintgen

  Lymphatic mapping in breast cancer

  Cancer Case Presentations: The Tumor Board. 1999;3(5):45-63.
  0

• 62.

  1999

  D.W. Ollila; D.L. Morton

  Tumor doubling time and survival [2]

  Journal of Surgical Oncology. 1999;71(4):249.
  3

• 63.

  1999

  David W. Ollila; Eddy C. Hsueh; Stacey L. Stern; Donald L. Morton

  Metastasectomy for recurrent stage IV melanoma

  Journal of Surgical Oncology. 1999;71(4):209-213.
  69

• 64.

  1999

  David W. Ollila; Leland J. Foshag; Richard Essner; Stacey L. Stern; Donald L. Morton

  Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma

  Annals of Surgical Oncology. 1999;6(2):150-154.
  48

• 65.

  1999

  Roderick R. Turner; David W. Ollila; Stacey Stern; Armando E. Giuliano

  Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging

  American Journal of Surgical Pathology. 1999;23(3):263-267.
  186

• 66.

  1999

  Donald L. Morton; David W. Ollila

  Surgical research review: Critical review of the sentinel node hypothesis

  Surgery. 1999;126(5):815-819.
  29

• 67.

  1999

  Donald L. Morton; David W. Ollila; Eddy C. Hsueh; Richard Essner; Rishab K. Gupta

  Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma

  Ca-A Cancer Journal for Clinicians. 1999;49(2):101-116.
  58

• 68.

  1998

  David W. Ollila; Meghan B. Brennan; Armando E. Giuliano

  Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer

  Archives of Surgery. 1998;133(6):647-651.
  33

• 69.

  1998

  Mark C. Kelley; David W. Ollila; Donald L. Morton

  Lymphatic mapping and sentinel lymphadenectomy for melanoma

  Seminars in Surgical Oncology. 1998;14(4):283-290.
  51

• 70.

  1998

  David W. Ollila; Mark C. Kelley; Guy Gammon; Donald L. Morton

  Overview of melanoma vaccines: Active specific immunotherapy for melanoma patients

  Seminars in Surgical Oncology. 1998;14(4):328-336.
  31

• 71.

  1998

  D.W. Ollila; D.L. Morton

  Surgical resection as the treatment of choice for melanoma metastatic to the lung

  Chest Surgery Clinics of North America. 1998;8(1):183-196.
  32

• 72.

  1998

  D.W. Ollila; A.E. Giuliano

  Sentinel lymphadenectomy: accurate histopathologic staging of the axilla.

  Oncology (Williston Park, N.Y.). 1998;12(7):1008.
  0

• 73.

  1998

  David W. Ollila; Stacey L. Stern; Donald L. Morton

  Tumor doubling time: A selection factor for pulmonary resection of metastatic melanoma

  Journal of Surgical Oncology. 1998;69(4):206-211.
  39

• 74.

  1997

  Arnold M. Conforti; David W. Ollila; Mark C. Kelley; Guy Gammon; Donald L. Morton

  Update on active specific immunotherapy with melanoma vaccines

  Journal of Surgical Oncology. 1997;66(1):55-64.
  22

• 75.

  1997

  Michael Bouvet; David W. Ollila; Kelly K. Hunt; Gildy V. Babiera; Francis R. Spitz; Armando E. Giuliano; Eric A. Strom; Frederick C. Ames; Merrick I. Ross; S. Eva Singletary

  Role of conservation therapy for invasive lobular carcinoma of the breast

  Annals of Surgical Oncology. 1997;4(8):650-654.
  32

• 76.

  1997

  Roderick R. Turner; David W. Ollila; David L. Krasne; Armando E. Giuliano

  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma

  Annals of Surgery. 1997;226(3):271-278.
  476

• 77.

  1996

  David W. Ollila; Richard Essner; Leslie A. Wanek; Donald L. Morton

  Surgical resection for melanoma metastatic to the gastrointestinal tract

  Archives of Surgery. 1996;131(9):975-980.
  145

• 78.

  1994

  J.H. Peters; D. Ollila; K.E. Nichols; G.D. Gibbons; M.A. Davanzo; J. Miller; M.E. Front; J.T. Innes; E.C. Ellison

  Diagnosis and management of bile leaks following laparoscopic cholecystectomy

  Surgical Laparoscopy and Endoscopy. 1994;4(3):163-170.
  29

• 79.

  1993

  J.H. Peters; J. Miller; K.E. Nichols; D. Ollila; D. Avrodopolous

  Laparoscopic cholecystectomy in patients admitted with acute biliary symptoms

  American Journal of Surgery. 1993;166(3):300-303.
  21